Finance

Lists
ZURA:NASDAQ
Zura Bio Ltd
$5.85
+1.74%
(+0.100) 1D
$5.85
0.00% (0.00)
After hours
Closed: Aug 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZURA...
Open
$5.78
High
$5.99
Low
$5.76
Mkt. cap
560.60M
Avg. vol.
756.01K
Volume
724.89K
52-wk high
$7.44
52-wk low
$1.88
EPS
-$1.12
Beta
-0.01
Shares outstanding
95.83M
No. of employees
40
Open
$5.78
High
$5.99
Low
$5.76
Mkt. cap
560.60M
Avg. vol.
756.01K
Volume
724.89K
52-wk high
$7.44
52-wk low
$1.88
EPS
-$1.12
Beta
-0.01
Shares outstanding
95.83M
No. of employees
40
News stories
From web sources and news partners
About Zura Bio Ltd
CEO-
Employees40
Founded2022
Headquarters-
SectorBiotechnology
Websitezurabio.com
Analyst ratings
Based on 5 analysts giving stock ratings to ZURA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ZURA in the last 3 months.
Highest
Current $5.85
$26.00 (+344.44%)
Average
$21.00 (+258.97%)
Lowest
$16.00 (+173.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Martin Fan
Wedbush
Buy
Maintained
$22.00
+276.1%
08/12/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$20.00
+241.9%
08/11/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
08/11/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$26.00
+344.4%
07/17/2026
Justin Kim
Oppenheimer
Buy
Reiterated
$16.00
+173.5%
06/08/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$11.00
+88%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.95M
10.96M
14.75M
20.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.57M
7.46M
10.75M
8.62M
Operating expense
19.52M
18.41M
25.50M
29.32M
Total operating expenses
19.52M
18.41M
25.50M
29.32M
Operating income
-19.52M
-18.41M
-25.50M
-29.32M
Other non operating income
-47.00K
-40.00K
-43.00K
1.02M
EBT including unusual items
-18.04M
-17.18M
-24.22M
-26.38M
EBT excluding unusual items
-18.04M
-17.18M
-24.22M
-26.38M
Income tax expense
-
-
-
-81.00K
Effective tax rate
-
-
-
0.31%
Other operating expenses
-
-
-
-
Net income
-18.04M
-17.18M
-24.22M
-26.30M
Net profit margin
-
-
-
-
Earnings per share
-
-0.49
-0.22
-0.21
Interest and investment income
1.53M
1.28M
1.32M
1.92M
Interest expense
-
-
-
-
Net interest expenses
1.53M
1.28M
1.32M
1.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.50M
-18.40M
-25.48M
-29.30M
Gain or loss from assets sale
-
-
3.00K
2.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps